Compare United Parcel Service Inc (UPS) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
United Parcel Service Inc vs State Street SPDR S&P Biotech ETF — how do they compare? United Parcel Service Inc trades at $94.48 (market cap $80.08B), while State Street SPDR S&P Biotech ETF trades at $150.49 (market cap $10.11B). The key difference: United Parcel Service Inc is far larger — about 7.9× State Street SPDR S&P Biotech ETF's market cap, and United Parcel Service Inc pays a 6.97% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold United Parcel Service Inc for 141 Days and State Street SPDR S&P Biotech ETF for 37 Days on average.
| UPS | XBI | |
|---|---|---|
Market Cap | $80.08B | $10.11B |
Volume | 6,706,833 | 12,903,266 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $120.00 | $169.55 |
52-Week Low | $82.87 | $104.99 |
Typical Hold Time | 141 Days | 37 Days |
Enterprise Value | $104.10B | — |
Dividend Yield | 6.97% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
UPS stock trades at $92.28, down 0.89% amid bearish technical signals and mixed fundamentals. The company maintains strong profitability with 29.66% ROE and has beaten earnings estimates for three consecutive quarters. Recent developments include the launch of UPS Secure Commerce and an exclusive TikTok Shop partnership, while facing headwinds from fuel costs and volume pressures. Analyst consensus remains positive with a $118.67 price target representing 29% upside potential.
The investment case balances attractive valuation metrics (P/E 17.5, P/S 0.89) against declining revenue trends and competitive threats. The 7% dividend yield provides income support, but investors face risks from margin compression and Amazon competition. Wall Street sentiment leans bullish despite recent price weakness, with improving domestic margins seen as the key catalyst.
XBI trades at $150.23, down 0.44% on the day, with a bearish technical signal driven by moving averages and oscillators. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts. Recent news highlights sector optimism from cancer vaccine breakthroughs and improved capital access, though the ETF carries higher volatility than broader healthcare funds.
The outlook is mixed: strong sector tailwinds from innovation and consolidation support growth potential, but high volatility and expense ratios relative to peers pose risks. Analyst sentiment is neutral with 100% hold ratings, suggesting cautious optimism amid technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
